Published clinical studies on both Longvida® and WokVel® offer a good amount of data to demonstrate the potential benefits from a dual mechanism approach to joint comfort and functionality through both 5-LOX and COX-2 pathways. The most relevant results supporting this approach are shown in the new WokVel® & Longvida® Infographic available in our electronic folder and LEHVOSS Nutrition website.
Known for its 5-lipoxygenase (5-LOX) inhibition activity, Boswellia serrata has been used traditionally as a joint solution supporting improved mobility, comfort, joint integrity, and healthy joint aging. Curcuma longa has a well-known and established cyclooxygenase-2 (COX-2) inhibition activity for favourable benefits promoting healthy joints, supporting improved antioxidant capacity, joint comfort, functionality, and healthy joint aging.
Adequate management of both the 5-LOX and COX-2 pathways offers a dual mechanistic approach joint comfort and functionality with clinically supported evidence for fast-acting, long-lasting benefits.
For more information, contact us.